Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02912546
Other study ID # 16/B/03
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2016
Est. completion date September 5, 2019

Study information

Verified date March 2021
Source University Hospital Center of Martinique
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postural changes are commonly used as therapeutic maneuver to enhance or reduce cerebral perfusion. For instance, in acute stroke, the patient can be positioned in head down tilt position so as to increase perfusion of cerebral tissues perfusion. In During stroke and in hypertensive patients and during stroke, varying degrees a various loss of cerebral autoregulation is loss are usually observed. The aim of this study is to assess cerebral perfusion with ASL perfusion in human subjects in different conditions: healthy, hypertensive and stroke.


Description:

Material and methods: Eighteen stroke patients, eighteen hypertensive patients and eighteen healthy subjects (men and women) will be enrolled. The investigator will use a 1.5 Tesla MRI device with a large magnet bore (70 cm) allowing positions change. Two measures will be performed, one in supine position and the other in head down position (-20°). A 3D FSE ASL sequence will be acquired and Cerebral Blood Flow (CBF) maps will be reconstructed. Volume of interest (VOI) will be placed on cortical grey matter (frontal and posterior gyrus), on subcortical deep grey matter (caudate nuclei, thalami) and subcortical white matter (semi oval centers). Differences in CBF values (in mL/100g/min) will be analyzed using SAS 9.3 software for Windows (SAS Institute, Cary North Carolina, USA). Expected results and hypothesis: CBF is expected to significantly vary between the supine and head down positions. It is expected to at least increase in the head down position, for stroke patients. For healthy subjects and hypertensive patients, cerebral autoregulation may limit CBF increase although an increasing trend for CBF is expected.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date September 5, 2019
Est. primary completion date December 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria: 1. Group of stroke patients: - Patients between 40 and 70 years old, male or female - With supratentorial ischemia in subacute phase (> H24) - Patients with a recent ischemic stroke with an intracranial hemodynamic unstable and kept lying with head down of about 30 - Patient given free and informed consent to participate in research or a family representative - Patient insured under the French social security system 2. Control Group: 1- Group of patients with Hypertension. - Patients between 40 and 70 years old, matched for age and sex to stroke patients. - With a hypertension diagnosed since 10 years old. - Hypertension defined as three recommendations (OMS 1999, ANAES 1997 JNC VI): blood pressure 140 and / or 90 mmHg found at several consultations. 2- Group with healthy people. - Healthy person between 30 and 70 years old, women and men. Healthy character will be defined on the basis of a physical examination (measurement of heart rate and blood pressure ) and an examination to determine the absence of endocrine pathology ... ) and the absence of drug outlet continuous. - Person insured under the French social security system. - Person who given free and informed his consent to participate in research or a family representative. - Person who are not participating in another clinical study. Exclusion Criteria: - Patients aged under 40 years and 71 years and older for patients in groups of stroke patients and patients with hypertension - Person under 30 years and 71 years and older for healthy people - Person who refuses or family the participation in the study - Person with heart antecedent or spinal disease - Contraindications to the realization of a MRI (pacemaker, claustrophobia, metallic body may be mobilized). - Person not insured under the French social security system, - Pregnant women - Persons under guardianship or curatorship - Persons deprived of liberty by a judicial or administrative decision - Persons who are participating in another clinical study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
MRI
A 1.5 Tesla MRI device with a large magnet bore (70 cm) allowing positions change will be used. Two measures will be performed, one in supine position and the other in head down position (-20°). A 3D FSE ASL sequence will be acquired and CBF maps reconstructed. Volume of interest (VOI) will be placed on cortical grey matter (frontal and posterior gyrus), on subcortical deep grey matter (caudate nuclei, thalami) and subcortical white matter (semi oval centers

Locations

Country Name City State
Martinique Centre Hospitalier Universitaire de Martinique Fort-de-France

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Center of Martinique

Country where clinical trial is conducted

Martinique, 

References & Publications (2)

Chalela JA, Alsop DC, Gonzalez-Atavales JB, Maldjian JA, Kasner SE, Detre JA. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke. 2000 Mar;31(3):680-7. — View Citation

Lovell AT, Marshall AC, Elwell CE, Smith M, Goldstone JC. Changes in cerebral blood volume with changes in position in awake and anesthetized subjects. Anesth Analg. 2000 Feb;90(2):372-6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The change in the value of the cerebral blood flow The endpoint is the change in the value of the cerebral blood flow ( ml / 100g / min) depending on the switching position ( 0 ° and -20 °). This development will be assessed in different brain regions . In particular, it will be searched in excess of a threshold of significance .
This will be accomplished independently by two experienced readers (knowing that the variation between and within road has been assessed) . If a significant difference between the two players, it will be made a consensual common measure.
up to 1 year
See also
  Status Clinical Trial Phase
Completed NCT05131295 - Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage. Phase 3
Completed NCT01955642 - Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke N/A
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Recruiting NCT01541163 - Heart and Ischemic STrOke Relationship studY N/A
Recruiting NCT06076122 - Salicornia for Neurovascular Health Improve N/A
Not yet recruiting NCT04386525 - Omega 3 and Ischemic Stroke; Fish Oil as an Option Phase 4
Recruiting NCT06270927 - A Feasibility Study for Randomization of Code Stroke Imaging Strategies
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Completed NCT05815836 - Precision Medicine in Stroke
Recruiting NCT01673932 - Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke Phase 1
Recruiting NCT01556802 - Use of Minocicline in Patients With Stroke Phase 1
Completed NCT02101606 - Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke Phase 2
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Terminated NCT00073372 - A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II) Phase 3
Recruiting NCT04908241 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) N/A
Recruiting NCT04188132 - EEG Based BCI for Upper Limb Rehabilitation in Stroke N/A
Completed NCT01713491 - Pre-stroke Cognitive Status and Thrombolytic Therapy N/A
Completed NCT01443962 - The Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy N/A
Terminated NCT01059149 - Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup) Phase 2
Recruiting NCT06081283 - Antiseizure Medication in Seizure Networks at Early Acute Brain Injury Phase 4